Related Experiment Video
Updated: Jun 28, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Brain lipid analysis in mice with Rett syndrome
Thomas N Seyfried1, Karie A Heinecke, John G Mantis
1Department of Biology, Boston College, Boston, MA 02467, USA. thomas.seyfried@bc.edu
Neurochemical Research
|November 13, 2008
Summary
Rett syndrome (RS) research found that Mecp2 mutations in mice did not cause widespread brain lipid abnormalities. Specifically, ganglioside GD1a was reduced in one mouse model, but overall lipid content remained largely unchanged.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Rett syndrome (RS) is a neurodevelopmental disorder linked to MECP2 gene mutations.
- Previous studies reported ganglioside abnormalities in the brains of RS patients.
Purpose of the Study:
- To investigate brain lipid distribution in mouse models of Rett syndrome.
- To determine if Mecp2 mutations are associated with significant alterations in brain lipids.
Main Methods:
- Analysis of total lipid distribution in the cerebrum/brainstem, hippocampus, and cerebellum of Mecp2 mutant mice (tm1.1Bird knockout and 308/y deletion).
- Quantification of specific lipids, including the ganglioside GD1a and myelin-enriched cerebrosides.
Main Results:
- A significant reduction in the neuronal ganglioside GD1a was observed in the cerebrum/brainstem of Mecp2 (tm1.1Bird) mice.
- No significant reduction in GD1a was found in Mecp2 (308/y) mice.
- No other major differences in brain lipid content, including cerebrosides, were detected in either mouse model.
Conclusions:
- The motor deficits observed in these RS mouse models are not linked to extensive brain lipid abnormalities.
- The findings suggest that previously observed brain lipid abnormalities in human RS patients may not be recapitulated in these specific Mecp2 mouse models.
